Your browser doesn't support javascript.
loading
Identification and validation of biomarkers for autism spectrum disorders.
Loth, Eva; Spooren, Will; Ham, Lindsay M; Isaac, Maria B; Auriche-Benichou, Caroline; Banaschewski, Tobias; Baron-Cohen, Simon; Broich, Karl; Bölte, Sven; Bourgeron, Thomas; Charman, Tony; Collier, David; de Andres-Trelles, Fernando; Durston, Sarah; Ecker, Christine; Elferink, Andre; Haberkamp, Marion; Hemmings, Robert; Johnson, Mark H; Jones, Emily J H; Khwaja, Omar S; Lenton, Sabine; Mason, Luke; Mantua, Valentina; Meyer-Lindenberg, Andreas; Lombardo, Michael V; O'Dwyer, Laurence; Okamoto, Koichi; Pandina, Gahan J; Pani, Luca; Persico, Antonio M; Simonoff, Emily; Tauscher-Wisniewski, Sitra; Llinares-Garcia, Jordi; Vamvakas, Spiros; Williams, Steve; Buitelaar, Jan K; Murphy, Declan G M.
Affiliation
  • Loth E; Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK.
  • Spooren W; Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Pharmaceuticals, Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Ham LM; Regulatory Affairs, Pharmaceutical Development, F. Hoffmann-La Roche Pharmaceuticals, Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Isaac MB; European Medicines Agency, 30 Churchill Place, London E14 5EU, UK.
  • Auriche-Benichou C; Agence Nationale de Sécurité du Médicament et des Produits de Santé, 143-147 Boulevard Anatole France, 93285 Saint-Denis Cedex, France.
  • Banaschewski T; Child and Adolescent Psychiatry, Central Institute of Mental Health, University of Heidelberg, Medical Faculty Mannheim, 68159 Mannheim, Germany.
  • Baron-Cohen S; Autism Research Centre, Department of Psychiatry, University of Cambridge, Douglas House, 18b Trumpington Road, Cambridge CB2 8AH, UK.
  • Broich K; Bundesinstitut für Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger Allee 3, 53175 Bonn, Germany.
  • Bölte S; Center of Neurodevelopmental Disorders, Department of Women's and Children's Health, Karolinska Institutet, CAP Research Center, Gävlegatan 22B, Floor 8, SE-113 30 Stockholm, Sweden.
  • Bourgeron T; Institut Pasteur, Unité Génétique Humaine et Fonctions Cognitives, 25 Rue du Docteur Roux, 75015 Paris Cedex 15, France.
  • Charman T; Clinical Child Psychology, Department of Psychology, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK.
  • Collier D; Discovery Neuroscience Research, Erl Wood, Lilly UK, Erl Wood Manor, Windlesham GU20 6PH, UK.
  • de Andres-Trelles F; Agencia Española de Medicamentos y Productos Sanitarios, Parque Empresarial Las Mercedes, Edifico 8, Calle Campezo 1, 28022 Madrid, Spain.
  • Durston S; Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Universiteitsweg 100, 3584 CG Utrecht, The Netherlands.
  • Ecker C; Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK.
  • Elferink A; College ter Beoordeling van Geneesmiddelen (Medicines Evaluation Board), Graadt van Roggenweg 500, 3531 AH Utrecht, The Netherlands.
  • Haberkamp M; Bundesinstitut für Arzneimittel und Medizinprodukte, Kurt-Georg-Kiesinger Allee 3, 53175 Bonn, Germany.
  • Hemmings R; Medicines and Healthcare Products Regulatory Agency, 151 Buckingham Palace Road, London SW1W 9SZ, UK.
  • Johnson MH; Centre for Brain and Cognitive Development, Birkbeck, University of London, 32 Torrington Square, London WC1E 7JL, UK.
  • Jones EJ; Centre for Brain and Cognitive Development, Birkbeck, University of London, 32 Torrington Square, London WC1E 7JL, UK.
  • Khwaja OS; Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Pharmaceuticals, Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Lenton S; College ter Beoordeling van Geneesmiddelen (Medicines Evaluation Board), Graadt van Roggenweg 500, 3531 AH Utrecht, The Netherlands.
  • Mason L; Centre for Brain and Cognitive Development, Birkbeck, University of London, 32 Torrington Square, London WC1E 7JL, UK.
  • Mantua V; Agenzia Italiana del Farmaco, Via del Tritone, 181, 00187, Rome, Italy.
  • Meyer-Lindenberg A; Central Institute of Mental Health, University of Heidelberg, Medical Faculty Mannheim, 68159 Mannheim, Germany.
  • Lombardo MV; Autism Research Centre, Department of Psychiatry, University of Cambridge, Douglas House, 18b Trumpington Road, Cambridge CB2 8AH, UK. Department of Psychology, University of Cyprus, PO Box 20537, 1678 Nicosia, Cyprus. Center for Applied Neuroscience, University of Cyprus, PO Box 20537, 1678 Nicosia
  • O'Dwyer L; Donders Center for Cognitive Neuroimaging, Radboud University Nijmegen Medical Centre, Kapittelweg 29, 6525 EN Nijmegen, The Netherlands.
  • Okamoto K; Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Pharmaceuticals, Grenzacherstrasse 124, CH-4070 Basel, Switzerland.
  • Pandina GJ; Janssen Research &Development, 1125 Trenton Harbourton Road, Titusville, New Jersey 08560, USA.
  • Pani L; Agenzia Italiana del Farmaco, Via del Tritone, 181, 00187, Rome, Italy.
  • Persico AM; University Campus Bio-Medico, Via Álvaro del Portillo, 21, 00128 Rome, Italy. Mafalda Luce Center for Pervasive Developmental Disorders, Via Bernardo Rucellai, 36, 20126 Milan, Italy.
  • Simonoff E; Department of Child and Adolescent Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK.
  • Tauscher-Wisniewski S; Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, Indiana 46285, USA.
  • Llinares-Garcia J; European Medicines Agency, 30 Churchill Place, London E14 5EU, UK.
  • Vamvakas S; European Medicines Agency, 30 Churchill Place, London E14 5EU, UK.
  • Williams S; Centre for Neuroimaging Sciences, Institute of Psychiatry, Psychology and Neurosciences, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK.
  • Buitelaar JK; Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen Medical Centre, Kapittelweg 29, 6525 EN Nijmegen, The Netherlands.
  • Murphy DG; Sackler Institute for Translational Neurodevelopment, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, Denmark Hill, London SE5 8AF, UK.
Nat Rev Drug Discov ; 15(1): 70-3, 2016 Jan.
Article in En | MEDLINE | ID: mdl-26718285
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autism Spectrum Disorder Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Autism Spectrum Disorder Type of study: Diagnostic_studies / Prognostic_studies Limits: Adolescent / Adult / Child / Child, preschool / Female / Humans / Male Language: En Journal: Nat Rev Drug Discov Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2016 Document type: Article Affiliation country: United kingdom